IMC Chicago’s Bristol-Myers Squibb BMY Stock Holding History

IMC Chicago’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.38M	Buy	+128,157	New	+$7.36M	﹤0.01%	1782
2026 Q1	–	Sell	-45,935	Closed	-$2.68M	–	5716
2025 Q4	$2.48M	Buy	+45,935	New	+$2.21M	﹤0.01%	2248
2023 Q2	–	Sell	-14,464	Closed	-$970K	–	1295
2023 Q1	$1M	Sell	14,464 -6,753	-32%	-$476K	﹤0.01%	1033
2022 Q4	$1.53M	Buy	+21,217	New	+$1.6M	﹤0.01%	896
2021 Q3	–	Sell	-12,674	Closed	-$835K	–	1192
2021 Q2	$847K	Buy	+12,674	New	+$826K	﹤0.01%	943
2021 Q1	–	Sell	-36,970	Closed	-$2.3M	–	1045
2020 Q4	$2.29M	Buy	+36,970	New	+$2.27M	﹤0.01%	707
2020 Q1	–	Sell	-245,836	Closed	-$15M	–	842
2019 Q4	$15.8M	Buy	+245,836	New	+$14.1M	0.04%	162
2019 Q3	–	Sell	-17,267	Closed	-$812K	–	732
2019 Q2	$783K	Buy	+17,267	New	+$804K	﹤0.01%	567

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

IMC Chicago's BMY Position: Q2 2026 in Review

IMC Chicago opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 128,157 shares worth $7.38M. The stake represents ﹤0.01% of the portfolio and ranks #1782 among its holdings. This is a return to the name: IMC Chicago previously reported a position in BMY as recently as Q4 2025.

IMC Chicago first reported a position in BMY in Q2 2019 and has held it in 8 quarters since. The position peaked at $15.8M in Q4 2019. 2,100 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

IMC Chicago held 128,157 shares of Bristol-Myers Squibb worth $7.38M as of Q2 2026.
Bristol-Myers Squibb was a new IMC Chicago position in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #1782 holding.
IMC Chicago first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 8 quarters since.
IMC Chicago's Bristol-Myers Squibb position peaked at $15.8M in Q4 2019.
2,100 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.